NIH-funded research R01 grant

Unusual bacterial fragments that may cause long-lasting Lyme symptoms

Official title: The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts

Funded at Northwestern University · NIH-11168835 · Data updated 2026-11-12

This work looks at whether pieces of the Lyme bacterium left behind after antibiotics cause ongoing joint pain in people who had Lyme disease.

More Lyme Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startJune 15, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$514,496
NIH project number5R01AI178711-03
Project IDNIH-11168835 on NIH RePORTER

Who could benefit from this research

Could help

People who previously had Lyme disease and still have joint pain or Lyme arthritis after completing recommended antibiotic therapy are the most likely candidates.

Less likely to help

People with newly diagnosed, untreated Lyme infection or whose symptoms are caused by a different condition may not benefit from this research.

What this research studies

Researchers will examine joint fluid and other samples from people who continue to have Lyme-related joint pain after standard antibiotic treatment to identify leftover bacterial cell-wall fragments. They will chemically map the unusual peptidoglycan pieces and track how long they remain in tissues. Parallel animal and lab experiments will test whether these fragments can trigger persistent inflammation and whether they can be targeted or removed. The team aims to link what is found in patients to specific approaches that could reduce lingering symptoms.

Why it matters

Potential benefit: If successful, this work could point to treatments that remove or neutralize leftover bacterial fragments and ease persistent Lyme arthritis.

How similar studies have gone: Animal studies have shown purified Borrelia peptidoglycan can cause arthritis and researchers have detected these fragments in patient joint fluid, but human treatments based on this idea are not yet proven.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Jutras, Brandon Lyon — Northwestern University
  • Study coordinator: Jutras, Brandon Lyon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.